Home
Scholarly Works
Defining minimal residual disease by flow...
Conference

Defining minimal residual disease by flow cytometry in acute myeloid leukemia: the HARMONIZE initiative

Authors

Bucklein VL; Krause S; Oelschlagel U; Kohnke T; Schnorfeil F; Volkl S; Rieger MA; Berg T; Hoffmann J; Brendel C

Volume

40 (Suppl. 3) (P192)

Publication Date

September 1, 2017

Conference start date

November 10, 2017

Conference proceedings

Oncol Res Treat

Contact the Experts team